Kidney & blood pressure research

Diabetic Kidney Disease: From How It Develops to Possible Treatments

Updated

Abstract

Chronic kidney disease (CKD) is primarily caused by diabetes mellitus (DM), which is the most common reason for renal replacement therapy (RRT).

  • Type II DM is the most prevalent form and is linked to the rising prevalence of metabolic syndrome.
  • The pathophysiology of diabetic kidney disease (DKD) involves complex mechanisms such as glomerular changes, hyperfiltration, and podocyte injury.
  • Gut microbiota has been identified as an important factor in the progression of DKD.
  • Current treatment options include angiotensin converting enzyme inhibitors (ACEi) and angiotensin receptor blockers (ARB), which focus on reducing albuminuria.
  • Emerging therapies like sodium-glucose transporter 2 (SGLT2) inhibitors, novel mineralocorticoid receptor antagonists (MRAs), and glucagon-like peptide 1 receptor antagonists (GLP1RA) are being explored for their impact on DKD.

Simplified

Full Text

Full text is available at the source.

Funding

Competing interests

The authors declare no conflict of interest.
PubMed

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • ✅direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free